How to measure the economic impact of vector-borne diseases at country level

Journal of Economic Surveys

Volumn 29, Issue 5, 2015, Pages 896-916

  Basili, Marcello ^a   Belloc, Filippo ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Economic growth; Health indicators; Vector borne diseases

Indexed keywords

COMPARATIVE STUDY; DISEASE INCIDENCE; DISEASE TRANSMISSION; DISEASE VECTOR; ECONOMETRICS; ECONOMIC GROWTH; ECONOMIC IMPACT; FUTURE PROSPECT; HEALTH GEOGRAPHY; MACROECONOMICS; NATIONAL ECONOMY; RESEARCH WORK; RESOURCE ALLOCATION;

EID: 84944517166     PISSN: 09500804     EISSN: 14676419     Source Type: Journal    
DOI: 10.1111/joes.12075     Document Type: Article

References (104)

1. Acemoglu, D. and Johnson, S. (2007) Disease and development: the effect of life expectancy on economic growth. Journal of Political Economy 115(6): 925-985.
2. Acemoglu, D. and Johnson, S. (2014) Disease and development: a reply to Bloom, Canning, and Fink. Journal of Political Economy 122(6): 1367-1375.
3. Aghion, P., Howitt, P. and Murtin, F. (2011) The relationship between health and growth: when Lucas meets Nelson-Phelps. Review of Economics and Institutions 2(1): 1-24.
4. Allanson, P. and Petrie, D. (2013) On the choice of health inequality measure for the longitudinal analysis of income-related health inequalities. Health Economics 22: 353-365.
5. Anand, S. and Hanson, K. (1997) Disability-adjusted life years: a critical review. Journal of Health Economics 16(6): 685-702.
6. Anand, S. and Hanson, K. (1998) DALYs: efficiency versus equity. World Development 26(2): 307-310.
7. Asante, F.A. and Asenso-Okyere, K. (2003) Economic burden of malaria in Ghana. Research Paper, Institute of Statistical, Social and Economic Research (ISSER), University of Ghana, Legon.
8. Asenso-Okyere, K., Osei-Akoto, I., Anun, A. and Appiah, E.N. (1997) Willingness to pay for health insurance in a developing economy. A pilot study of the informal sector of Ghana using contingent valuation. Health Policy 42(3): 223-237.
9. Barlow, R. (1967) The economic effects of malaria eradication. American Economic Review 57(2): 130-148.
10. Bärnighausen, T., Bloom, D.E. and O'Brien, J. (2008) Accounting for the full benefits of childhood vaccination in South Africa. South African Medical Journal 98(11): 842-846.
11. Bärnighausen, T., Bloom, D.E., Canning, D., Friedman, A., Levine, O.S., O'Brien, J., Privor-Dumm, L. and Walker, D. (2011) Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenza type b vaccine. Vaccine 29(13): 2371-2380.
12. Barreca, A.I. (2010) The long-term economic impact of in utero and postnatal exposure to malaria. Journal of Human Resources 45(4): 865-892.
13. Becker, G.S., Philipson, T.J. and Soares, R.R. (2005) The quantity and quality of life and the evolution of world inequality. American Economic Review 95: 277-291.
14. Bhargava, A., Jamison, D., Lau, L. and Murray, C. (2001) Modelling the effects of health on economic growth. Journal of Health Economics 20(3): 423-440.
15. Bleakley, H. (2003) Disease and development: evidence from the American South. Journal of the European Economic Association 1(2-3): 376-386.
16. Bleakley, H. (2010) Malaria eradication in the Americas: a retrospective analysis of childhood exposure. American Economic Journal: Applied Economics 2(2): 1-45.
17. Bloom, D.E. and Canning, D. (2000) The health and wealth of nations. Science 287(5456): 1207-1209.
18. Bloom, D.E., Canning, D. and Fink, G. (2014) Disease and development revisited. Journal of Political Economy 122(6): 1355-1366.
19. Bloom, D.E. and Fink, G. (2014) The economic case for devoting public resources to health. In J. Farrar, Hotez, P., Junghanss, T., Kang, G., Lalloo, D. and White, N.J. (eds), Manson's Tropical Diseases. New York: Saunders.
20. Bonds, M.H., Keenan, D., Rohani, P. and Sachs, J. (2009) Poverty trap formed by the ecology of infectious diseases. Proceedings of the Royal Society, Series B 277: 1185-1192.
21. Bourguignon, F. and Morrisson, C. (2002) Inequality among world citizens: 1820-1992. American Economic Review 92: 727-744.
22. Brooker, S., Guyatt, H., Omumbo, J., Shretta, R., Drake, L. and Ouma, J. (2000) Situation analysis of malaria in school-aged children in Kenya: what can be done? Parasitology Today 16(5): 183-186.
23. Busschbach, J.J.V., Jessing, D.J. and de Charro, F.T. (1993) The utility of health at different stages of life: a quantitative approach. Social Science and Medicine 37(2): 153-158.
24. Cervellati, M. and Sunde, U. (2011) Life expectancy and economic growth: the role of the demographic transition. Journal of Economic Growth 16(2): 99-133.
25. Chima, R.I., Goodman, C.A. and Mills, A. (2003) The economic impact of malaria in Africa: a critical review of the evidence. Health Policy 63(1): 17-36.
26. Clark, D., Mammen, P., Nisalak, A., Puthimethee, V. and Endy, T.P. (2005) Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. American Journal of Tropical Medicine and Hygiene 72(6): 786-791.
27. Clarke, S.E., Jukes, M.C.H., Njagi, J.K., Khasakhala, L., Cundill, B., Otido, J., Crudder, C., Estambale, B.B. and Brooker, S. (2008) Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, doubleblind, placebo-controlled trial. Lancet 372: 127-138.
28. Conly, G.N. (1972) The impact of malaria on economic development: a case study. American Journal of Tropical Medicine and Hygiene 21(5): 668-674.
29. Cropper, M.L., Aydede, S.K. and Portney, P.R. (1994) Preferences for life saving programs: how the public discounts time and age. Journal of Risk and Uncertainty 37(8): 153-158.
30. Cropper, M.L., Haile, M., Lampietti, J.A., Poulos, C. and Whittington, D. (2000) The value of preventing malaria in Tembien, Ethiopia. Research Paper, World Health Organization, Washington, D.C.
31. Davis, K., Mitra, D., Medjedovic, J., Beam, C. and Rustgi, V. (2011) Direct economic burden of chronic hepatitis C virus in a United States managed care population. Journal of Clinical Gastroenterology 45(2): 17-24.
32. Diamond, P.A. and Hausman, J.A. (1994) Contingent valuation: is some number better than no number? Journal of Economic Perspectives 8(4): 45-64.
33. Eggleston, K. and Fuchs, V. (2012) The new demographic transition: most gains in life expectancy now realized late in life. Journal of Economic Perspectives 26: 137-156.
34. Ettling, M.B. and Shepard, D.S. (1991) Economic cost of malaria in Rwanda. Tropical Medicine and Parasitology 42(3): 214-218.
35. Frew, E.J., Wolstenholme, J.L. and Whynes, D.K. (2004) Comparing willingness-to-pay: bidding game format versus open-ended and payment scale formats. Health Policy 68(3): 289-298.
36. Galloway, P.R. (1988) Basic patterns in annual variations in fertility, nuptiality, mortality, and prices in preindustrial Europe. Population Studies 42(2): 275-302.
37. Gallup, J.L. and Sachs, J. (2001) The economic burden of malaria. American Journal of Tropical Medicine and Hygiene 61(1-2): 85-96.
38. Gersovitz, M. and Hammer, J. S. (2004) The economical control of infectious diseases. Economic Journal 114(492): 1-27.
39. Gollin, D. and Zimmermann, C. (2012) Global climate change, the economy, and the resurgence of tropical disease. Mathematical Population Studies 19(1): 51-62.
40. Hausman, J.A. (1978) Specification tests in econometrics. Econometrica 46(6): 1251-1271.
41. Hedberg, K., Shaffer, N., Davachi, F., Hightower, A., Lyamba, B., Paluku, K.M., Nguyen-Dinh, P. and Breman, J.G. (1993) Plasmodium falciparum-associated anemia in children at a large urban hospital in Zaire. American Journal of Tropical Medicine and Hygiene 48(3): 365-371.
42. Hendrickx, G. and Lancelot, R. (2010) A perspective on emerging mosquito and phlebotomine-borne diseases in Europe. Eurosurveillance 15(10): 2-3.
43. Holding, P.A. and Snow, R.W. (2001) Impact of Plasmodium falciparum malaria on performance and learning: review of the evidence. American Journal of Tropical Medicine and Hygiene 64(1-2): 68-75.
44. Hsia, E.C., Chung, J.B., Schwartz, J.S. and Albert, D.A. (2002) Cost-effectiveness analysis of the Lyme disease vaccine. Arthritis & Rheumatism 46(6): 1651-1660.
45. Hyder, A.A., Rotllant, G. and Morrow, R.H. (1998) Measuring the burden of disease: healthy life-years. American Journal of Public Health 88(2): 196-202.
46. Institute of Health Metrics and Evaluation (2013) The Global Burden of Disease: Generating Evidence, Guiding Policy. University of Washington.
47. Jamison, D.T., Lau, L.J. and Wang, J. (2005) Health's contribution to economic growth in an environment of partially endogenous technical progress. In G. Lopez-Casasnovas, B. Rivera and L. Currais (eds), Health and Economic Growth: Findings and Policy Implications. Cambridge, MA: MIT Press.
48. Jamison, D.T., Summers, L.H., Alleyne, G., Arrow, K.J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R.G.A., Frenk, J., Ghosh, G., Goldie, S.J., Guo, Y., Gupta, S., Horton, R., Kruk, M.E., Mahmoud, A., Mohohlo, L.K., Ncube, M., Pablos-Mendez, A., Reddy, K.S., Saxenian, H., Soucat, A., Ulltveit-Moe, K.H. and Yamey, G. (2013) Global health 2035: a world converging within a generation. The Lancet Commissions. Lancet 382: 1898-1955.
49. Johannesson, M. and Johansson, P.O. (1997) Is the valuation of a QALY gained independent of age? Some empirical evidence. Journal of Health Economics 16(5): 589-599.
50. Kochar, A. (2004) Ill-health, savings and portfolio choices in developing economies. Journal of Development Economics 73(1): 257-285.
51. Korenromp, E.L., Williams, B.G., Gouws, E., Dye, C. and Snow, R.W. (2003) Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Journal of Infectious Diseases 3(6): 349-358.
52. Kremer, M. and Miguel, E. (2007) The illusion of sustainability. Quarterly Journal of Economics 122(3): 1007-1065.
53. Leighton, C. and Foster, R. (1993) Economic impact of malaria in Kenya and Nigeria. Major Applied Research Paper No 6, Health Services Division, Bureau of Reserach and Development Agency for International Development, Bethesda, USA.
54. Lim, S., Vos, T., Flaxman, A. et al. (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224-2260.
55. Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, D.T. and Murray, C.J.L. (eds). (2006) Global Burden of Disease and Risk Factors. Washington, D.C.: World Bank.
56. Lorentzen, P., McMillan, J. and Wacziarg, R. (2008) Death and development. Journal of Economic Growth 13(2): 81-124.
57. Lucas, A.M. (2010) Malaria eradication and educational attainment: evidence from Paraguay and Sri Lanka. American Economic Journal: Applied Economics 2(2): 46-71.
58. Maes, E., Lecomte, P. and Ray, N. (1998) A cost-of-illness study of Lyme disease in the United States. Clinical Therapeutics 20(5): 993-1008.
59. Malaney, P. (2003) Micro-economic approaches to evaluating the burden of malaria. CID Working Paper No. 99, Center for International Development at Harvard University, Cambridge, MA.
60. Malaney, P., Spielman, A. and Sachs, J. (2004) The malaria gap. American Journal of Tropical Medicine and Hygiene 71(2): 141-146.
61. Mathers, C.D., Vos, T. and Stevenson, C. (1999) The Burden of Disease and Injury in Australia. Canberra: Australian Institute of Health and Welfare.
62. McCarthy, F.D., Wolf, H. and Wu, Y. (2000) The growth costs of malaria. NBER Working Paper Series No. 7541, Cambridge, MA.
63. Meltzer, M., Dennis, D. and Orloski, K. (1999) The cost effectiveness of vaccinating against Lyme disease. Emerging Infectious Diseases 5(3): 321-328.
64. Momota, A., Tabata, K. and Futagami, K. (2005) Infectious disease and preventive behavior in an overlapping generations model. Journal of Economic Dynamics and Control 29(10): 1673-1700.
65. Montalvo, J.G. and Reynal-Querol, M. (2007) Fighting against malaria: prevent wars while waiting for the 'miraculous' vaccine. Review of Economics and Statistics 89(1): 165-177.
66. Moran, M., Guzman, J., Henderson, K., Liyanage, R., Wu, L., Chin, E., Chapman, N., Abela-Oversteegen, L., Gouglas, D. and Kwong, D. (2012) Neglected Disease Research and Development: A Five Year Review. Sydney: Policy Cures.
67. Murray, C.J.L. (1994) Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bulletin of the World Health Organization 72(3): 429-445.
68. Murray, C.J.L. and Acharya, A.K. (1997) Understanding DALYs. Journal of Health Economics 16(6): 703-730.
69. Murray, C.J.L., Vos, T., Lozano, F. et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223.
70. Onwujekwe, O., Chima, R., Okonkwo, P. (2000) Economic burden of malaria illness on households versus that of all other illness episodes: a study in five malaria holo-endemic Nigerian communities. Health Policy 54(2): 143-159.
71. Onwujekwe, O., Chima, R., Shu, E., Nwagbo, D., Akpala, C. and Okonkwo, P. (2002) Altruistic willingness to pay in community-based sales of insecticide-treated nets exists in Nigeria. Social Science and Medicine 54(4): 519-527.
72. Pratt, J.W. and Zeckhauser, R.J. (1996) Willingness to pay and the distribution of risk and wealth. Journal of Political Economy 104(4): 747-763.
73. Ramsey, S. (2008) How should we value lives lost to cancer? Journal of the National Cancer Institute 100(24): 1742-1743.
74. Rice, D.P. (1967) Estimating the cost of illness. American Journal of Public Health and the Nations Health 57(3): 409-423.
75. Rijal, S., Koirala, S., Van der Stuyft, P. and Boelaertb, M. (2006) The economic burden of visceral leishmaniasis for households in Nepal. Transactions of the Royal Society of Tropical Medicine and Hygiene 100(9): 838-841.
76. Rowe, A.K., Steketee, R.W., Rowe, S.Y., Korenromp, E.l., Armstrong Schellenberg, J., Stein, C., Nahlen, B., Bryce, J., Black, R. and Stetekee, R. (2004) Estimates of the burden of mortality directly attributable to malaria for children under five years of age in Africa for the year 2000. Final Report for the Child Health Epidemiology Reference Group. Available at http://www.who.int/child-adolescent-health/New_Publications/CHILD_HEALTH/EPI/CHERG_Malaria_ Mortality.pdf (Last accessed June 16, 2014).
77. Russell, S. (2004) The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency syndrome. American Journal of Tropical Medicine and Hygiene 71(2): 147-155.
78. Sachs, J. and Malaney, P. (2002) The economic and social burden of malaria. Nature 415: 680-685.
79. Sachs, J.D., Kiszewski, A.D., Spielmann, M.A., Mellinger, A., Malaney, P. and Sachs, S.E. (2004) A global index of the stability of malaria transmission. American Journal of Tropical Medicine and Hygiene 70(5): 486-498.
80. Sauerborn, R., Adams, A. and Hien, M. (1996) Household strategies to cope with the economic costs of illness. Social Science and Medicine 43(3): 291-301.
81. Sawyer, D. (1993) Economic and social consequences of malaria in new colonization projects in Brazil. Social Science and Medicine 37(9): 1131-1136.
82. Scholz, B.D., Gross, R., Schultink, W. and Sastroamidjojo, S. (1997) Anaemia is associated with reduced productivity of women workers even in less-physically-strenuous tasks. British Journal of Nutrition 77(1): 47-57.
83. Seyler, T., Hutin, Y., Ramanchandran, V., Ramakrishnan, R., Manickam, P. and Murhekar, M. (2010) Estimating the burden of disease and the economic cost attributable to chikungunya, Andhra Pradesh, India, 2005-2006. Transactions of the Royal Society of Tropical Medicine and Hygiene 104(2): 133-138.
84. Shadick, N., Liang, M., Phillips, C., Fossel, K. and Kuntz, K.M. (2001) The cost effectiveness of vaccination against Lyme disease. Archives of Internal Medicine 161(4): 554-561.
85. Shepard, D.S., Ettling, M.B., Brincmann, U. and Sauerborn, R. (1991) The economic cost of malaria in Africa. Tropical Medicine and Parasitology 42(3): 199-203.
86. Shiell, A., Gerard, K., and Donaldson, C. (1987) Cost of illness studies: an aid to decision-making? Health Policy 8(3): 317-323.
87. Shiff, C., Checkley, W., Winch, P., Premji, Z., Minjas, J. and Lubega, P. (1996) Changes in weight gain and anaemia attributable to malaria in Tanzanian children living under holoendemic conditions. Transactions of the Royal Society of Tropical Medicine 90(3): 262-265.
88. Snow, R.W., Craig, M., Deichmann, U. and Marsh, K. (1999) Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bulletin of the World Health Organization 77(8): 624-640.
89. Spence, M. and Lewis, M. (eds). (2009) Health and Growth. Washington, D.C.: World Bank.
90. Suaya, J.A., Shepard, D.S., Siqueira, J.B., Martelli, C.T., Lum, L.C., Tan, L.H., Kongsin, S., Jiamton, S., Garrido, F., Montoya, R., Armien, B., Huy, R., Castillo, L., Caram, M., Sah, B.K., Sughayyar, R., Tyo, K.R. and Halstead, S.B. (2009) Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. American Journal of Tropical Medicine and Hygiene 80(5): 846-855.
91. Sutherst, R.W. (2004) Global change and human vulnerability to vector-borne diseases. Clinical Microbiology Reviews 17(1): 136-173.
92. Takken, W. and Knols, B.G.J. (2007) Emerging Pests and Vector-Borne Diseases in Europe. Wageningen, the Netherlands: Wageningen Academic Publishers.
93. Thurow, R. (2001) As a tropical scourge makes a comeback, so, too, does DDT. Wall Street Journal, July 26.
94. Viscusi, W. and Aldy, J. (2003) The value of a statistical life: a critical review of market estimates throughout the world. Journal of Risk and Uncertainty 27(1): 5-76.
95. Vos, T., Flaxman, A., Naghavi, M. et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2163-2196.
96. Weaver, M., Ndamobissi, R., Kornfield, R., Blewane, C., Sathe, A., Chapko, M., Bendje, N., Nguembi, E. and Senwara-Defiobona, J. (1996) Willingness to pay for child survival: results of a national survey in Central African Republic. Social Science and Medicine 43(6): 985-998.
97. Weil, D. (2007) Accounting for the effect of health on economic growth. Quarterly Journal of Economics 122(3): 1265-1306.
98. Wen, T.H., Lin, M.H. and Fang, C.T. (2012) Population movement and vector-borne disease transmission: differentiating spatial-temporal diffusion patterns of commuting and noncommuting dengue cases. Annals of the Association of American Geographers 102(5): 1026-1037.
99. WHO (2009) World Malaria Report. Geneva: World Health Organization.
100. WHO (2011) The Global Economic Burden of Non-Communicable Diseases. Geneva: World Health Organization.
101. Williams, A. (1999) Calculating the global burden of disease: time for a strategic reappraisal? Health Economics 8(1): 1-8.
102. Wooldridge, J.M. (2005) Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: The MIT Press.
103. Zaghi, D., Calaciura, B., Spinelli, O., Basili, M. and Romi, R. (2010) Literature Study on the Impact of Biodiversity Changes on Human Health. Report for the European Commission (Directorate General Environment), July 2010.
104. Zohrabian, A., Meltzer, M.I., Ratard, R., Billah, K., Molinari, N.A., Roy, K., Scott, D. and Petersen, L.R. (2004) West Nile virus economic impact, Louisiana, 2002. Emerging Infectious Diseases 10(10): 1736-1744.